4//SEC Filing
Suzdak Peter David 4
Accession 0001140361-13-004992
CIK 0001228627other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 5:20 PM ET
Size
5.5 KB
Accession
0001140361-13-004992
Insider Transaction Report
Form 4
Suzdak Peter David
Chief Executive Officer
Transactions
- Award
Stock Option (right to purchase)
2013-02-04+1,200,000→ 1,200,000 totalExercise: $0.37From: 2013-02-04Exp: 2023-02-04→ Common Stock (1,200,000 underlying)
Documents
Issuer
REXAHN PHARMACEUTICALS, INC.
CIK 0001228627
Entity typeother
Related Parties
1- filerCIK 0001296629
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 5:20 PM ET
- Size
- 5.5 KB